RxSight (RXST) FCF Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
RxSight (RXST) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 194.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 984.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 641.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 66.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 119.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 1,788.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -177.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -395.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -473.00 |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -1,649.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,649.00 |
| Mar 31, 2026 | -1,289.00 |
| Dec 31, 2025 | 579.00 |
| Sep 30, 2025 | -454.00 |
| Jun 30, 2025 | -167.00 |
| Mar 31, 2025 | 1,338.00 |
| Dec 31, 2024 | 2,191.00 |
| Sep 30, 2024 | 3,762.00 |
| Jun 30, 2024 | 2,911.00 |
| Mar 31, 2024 | 6,764.00 |
| Dec 31, 2023 | 5,375.00 |
| Sep 30, 2023 | 8,610.00 |
| Jun 30, 2023 | 9,498.00 |
| Mar 31, 2023 | 6,587.00 |
| Dec 31, 2022 | 1,948.00 |
| Sep 30, 2022 | 11,712.00 |
| Jun 30, 2022 | 12,143.00 |
| Mar 31, 2022 | 13,684.00 |
| Dec 31, 2021 | 7,052.00 |
| Sep 30, 2021 | -6,104.00 |